Jeff Tangney is the Co-Founder and CEO of Doximity (NYSE: DOCS), the largest professional medical network in the United States. Since founding the company in 2010, Tangney has built Doximity into a platform used by over 80% of U.S. physicians — more than 1.8 million medical professionals. Under his leadership, Doximity went public on the NYSE in June 2021 and has grown into a consistently profitable health-tech company with annual revenue exceeding $570 million. A serial entrepreneur with prior success co-founding Epocrates, Tangney is now spearheading Doximity’s expansion into AI-powered tools for physicians.

Jeff Tangney – Quick Facts

Doximity Competitors

Doximity operates at the intersection of healthcare technology and professional networking. The key competitors and comparable companies include:

• Epocrates (Athenahealth) – clinical decision support and drug reference tools for physicians
• Medscape (WebMD Health) – medical news, education, and clinical tools
• UpToDate (Wolters Kluwer) – evidence-based clinical decision support
• Sermo – global physician social network
• Figure 1 – medical image-sharing platform for healthcare professionals
• Teladoc Health – telehealth services (competes with Doximity’s video platform)
• Amion / QGenda – physician scheduling solutions
• LinkedIn – general professional networking (broad overlap)

Jeff Tangney Net Worth 2026 – Doximity CEO Salary

As of 2026, Jeff Tangney’s net worth is estimated at approximately $86 million based on his directly held shares — approximately 2.1 million shares of Doximity stock. However, this figure represents only his direct holdings; when his broader ownership stake (including trusts and entities) is factored in, he holds approximately 27% of the company, which at Doximity’s current market cap of roughly $5 billion would be valued at over $1.25 billion. At the company’s 2021 IPO, his total stake was worth approximately $3 billion.

In February 2025, Tangney sold approximately 1 million shares for roughly $76 million. His base salary of just $295,000 per year is one of the lowest among public company CEOs in the healthcare sector, with 96.5% of his total compensation coming from equity and bonuses.

Doximity CEO Compensation Breakdown

Doximity Net Worth 2026 – Is Doximity Profitable?

Yes, Doximity is a consistently profitable company with strong margins. Under CEO Jeff Tangney, the company has demonstrated impressive growth and profitability since its 2021 IPO.

Doximity Financial Summary

Doximity CEO Email Address | Jeff Tangney Contact

Below are the official contact details for Doximity CEO Jeff Tangney:

Early Life & Education

Jeff Tangney was born in 1974 in San Mateo, California, in the San Francisco Bay Area. From a young age, Tangney demonstrated exceptional aptitude in mathematics — he was twice the Wisconsin State high school math champion, an achievement that foreshadowed his analytical approach to healthcare technology.

Tangney earned his Bachelor of Science in Economics from Concordia University of Wisconsin, graduating summa cum laude. His strong quantitative foundation in economics served him well in his future career at the intersection of healthcare and technology. He went on to earn his MBA from Stanford University’s Graduate School of Business (1997–1999), one of the world’s most prestigious business programs.

Education Summary

Career History

Jeff Tangney’s career spans over three decades in healthcare consulting, finance, and technology. Before founding Doximity, he built a reputation as a healthcare innovator through multiple successful ventures.

Jeff Tangney Career Timeline

ZS Associates & Goldman Sachs (1993–1999)

Tangney began his career at ZS Associates, a global management consulting firm specializing in sales and marketing. For four years (1993–1997), he worked as a Manager focused on pharmaceutical marketing strategy, gaining deep expertise in the healthcare industry’s commercial landscape. After earning his MBA at Stanford, he spent a summer at Goldman Sachs as a healthcare investment banker, where he gained financial expertise in healthcare M&A and public offerings.

Epocrates (1999–2009)

Tangney co-founded Epocrates, which became one of the first and most successful medical smartphone applications. As COO and EVP of Sales, he helped build the platform into an essential clinical reference tool used by hundreds of thousands of physicians. Epocrates was later acquired by Athenahealth for $293 million in 2013, validating Tangney’s early vision that physicians would adopt mobile technology for clinical decision-making.

Founding Doximity (2010)

In 2010, after a brief stint as Entrepreneur in Residence at InterWest Partners, Tangney co-founded Doximity alongside Shari Buck and Nate Gross. The vision was to create a verified, physician-only professional network — essentially a “LinkedIn for doctors.” The platform launched with a focus on secure communication, credential verification, and medical news, eventually expanding into telehealth, e-faxing, and AI-powered tools.

Doximity CEO Role – Leadership & Achievements

Under Jeff Tangney’s leadership, Doximity has achieved several major milestones that have cemented its position as the dominant professional network for U.S. physicians:

• NYSE IPO (June 2021) — Led Doximity to a successful public offering at approximately $10 billion market cap, one of the largest health-tech IPOs of the year
• 80%+ Physician Penetration — Built a network of over 1.8 million verified medical professionals, covering more than 80% of U.S. physicians
• Consistent Profitability — Achieved a 55% adjusted EBITDA margin in FY2025, making Doximity one of the most profitable SaaS companies in healthcare
• Revenue Growth — Grew annual revenue from under $100 million at IPO to over $570 million in FY2025, with FY2026 guidance projecting $619M–$631M
• AI Expansion (2025–2026) — Spearheading Doximity’s push into AI-powered physician tools, with Tangney declaring the company’s ambition to “win the AI market in 2026”
• Telehealth Integration — Doximity’s video platform became widely used during COVID-19 and continues to be a core offering

Awards & Recognition

• Ernst & Young Entrepreneur of the Year (2005)
• PharmaVoice 100 Most Inspiring (2006, 2008)
• Two-Time Wisconsin State Math Champion (high school)
• ViVE 2026 Featured Speaker — Keynote on AI in healthcare

Jeff Tangney Wiki – Age, Family & Personal Life

Jeff Tangney (age 51, born 1974) is based in the San Francisco Bay Area, near Doximity’s headquarters. He is married to his wife Claudia, and together they have two children. Tangney is known for keeping his personal life private, preferring to let his professional achievements speak for themselves.

Tangney’s passion for healthcare technology was ignited during his years at ZS Associates, where he saw firsthand the inefficiencies in pharmaceutical marketing and physician communication. This experience, combined with his entrepreneurial drive, led him to co-found first Epocrates and then Doximity — two platforms that have collectively transformed how American doctors access clinical information and connect with colleagues.

An interesting personal fact: Tangney was twice the Wisconsin State high school math champion before going on to graduate summa cum laude in Economics. His quantitative mindset continues to influence how he approaches building products for physicians, with Doximity’s data-driven approach to physician engagement being a key competitive advantage.

About Doximity

Doximity, Inc. (NYSE: DOCS) is the largest professional medical network in the United States, headquartered in San Francisco, California. Founded in 2010 by Jeff Tangney, Shari Buck, and Nate Gross, the platform is used by over 80% of U.S. physicians and more than 1.8 million healthcare professionals.

Doximity’s core offerings include:

• Secure Messaging — HIPAA-compliant messaging between physicians
• Doximity Dialer & Video — Telehealth and patient communication tools
• News Feed — Curated medical news and clinical updates
• Credential Verification — Digital credentialing for hospitals and health systems
• AI-Powered Tools — Emerging suite of artificial intelligence features for clinical workflow
• Pharmaceutical Marketing — Targeted messaging platform for pharma companies to reach verified physicians

The company generates the majority of its revenue from pharmaceutical and health system clients who use the platform to reach and engage physicians. Doximity went public on the NYSE in June 2021 and has been consistently profitable since, with an industry-leading adjusted EBITDA margin of 55%.

Frequently Asked Questions (FAQ)

Who is the CEO of Doximity?

The CEO of Doximity is Jeff Tangney, who co-founded the company in 2010 alongside Shari Buck and Nate Gross. Tangney has served as CEO since the company’s inception and led it through its NYSE IPO in June 2021.

What is Jeff Tangney’s net worth in 2026?

Jeff Tangney’s net worth is estimated at approximately $86 million based on his directly held Doximity shares (~2.1 million shares). His broader ownership stake of approximately 27% of Doximity, including trusts and entities, would value his holdings at over $1.25 billion based on current market capitalization.

What is Jeff Tangney’s salary at Doximity?

Jeff Tangney’s base salary is just $295,000 per year — one of the lowest among public company CEOs in healthcare. His total annual compensation, including equity awards and bonuses, is approximately $17.23 million, with 98.3% coming from performance-based compensation.

What is Doximity’s CEO email address?

Doximity’s corporate email domain is @doximity.com. For investor inquiries, contact [email protected]. For press inquiries, contact [email protected]. The corporate headquarters is at 500 3rd Street, Suite 510, San Francisco, CA 94107, and can be reached at (650) 549-4500.

What is Doximity?

Doximity is the largest professional network for U.S. physicians, with over 80% of American doctors on the platform (1.8M+ medical professionals). It offers secure messaging, telehealth video tools, curated medical news, credential verification, and AI-powered clinical tools. The company trades on the NYSE under the ticker DOCS.

Did Jeff Tangney found any other companies?

Yes, before Doximity, Jeff Tangney co-founded Epocrates, one of the first medical smartphone applications. Epocrates became an essential clinical reference tool for physicians and was later acquired by Athenahealth for $293 million in 2013.

Is Doximity profitable?

Yes, Doximity is consistently profitable with an adjusted EBITDA margin of 55% in FY2025. The company generated $570.4 million in revenue and $313.8 million in adjusted EBITDA. FY2026 guidance projects revenue of $619M–$631M with continued strong margins.

Article last updated: March 2026